Please login to the form below

Not currently logged in
Email:
Password:

Elliott Levy joins Amgen from BMS

He is appointed senior VP, global development

Dr Elliott Levy has left his role at Bristol-Myers Squibb to join Amgen as senior VO, global development.

Levy was most recently senior VP and head of specialty development at BMS, where he spent 17 years.

During this time he served in a number of senior roles including head of global pharmacovigilance and epidemiology.

“Elliott brings a wealth of development and leadership experience to his new role at Amgen,” said Dr Sean Harper, executive VP of R&D at Amgen.

“His track record shows his success in leading major clinical development programmes, and we're confident that he will help Amgen to serve patients by advancing the large number of potential new medicines in our late-stage pipeline.”

26th August 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics